Immunovant, Inc. ($IMVT)
Filing Information
| Accession Number | 0001341896-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 29, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
615,153
Total Value
$9,053,438.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 28, 2026 | Exercise/Conversion | 31,668 | $4.99 | $158,023.32 | 131,400 | Direct | โ | View Details | |
Director | Common Stock | โ | May 28, 2026 | Exercise/Conversion | 71,492 | $7.94 | $567,646.48 | 202,892 | Direct | โ | View Details | |
Director | Common Stock | โ | May 28, 2026 | Exercise/Conversion | 77,181 | $8.43 | $650,635.83 | 280,073 | Direct | โ | View Details | |
Director | Common Stock | โ | May 28, 2026 | Exercise/Conversion | 16,260 | $14.70 | $239,022.00 | 296,333 | Direct | โ | View Details | |
Director | Common Stock | โ | May 28, 2026 | Sale | 11,483 | $32.64 | $374,805.12 | 284,850 | Direct | โ | View Details | |
Director | Common Stock | โ | May 28, 2026 | Sale | 210,468 | $33.56 | $7,063,306.08 | 74,382 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 28, 2026 | Exercise/Conversion | 31,668 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 28, 2026 | Exercise/Conversion | 71,492 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 28, 2026 | Exercise/Conversion | 77,181 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 28, 2026 | Exercise/Conversion | 16,260 | $0.00 | $0.00 | 0 | Direct | โ | View Details |